Literature DB >> 7814244

Genetic heterogeneity of hepatitis C virus.

H Okamoto1, S Mishiro.   

Abstract

There are four hierarchical strata in the genetic heterogeneity of hepatitis C virus (HCV): group above subgroup above isolates above quasispecies. The entire genome sequence has so far been reported for 16 isolates which are classifiable into 3 groups and 6 subgroups. Provisional classification of HCV is also possible using a partial sequence of the HCV genome. With the E1 region sequence for example, the present collection of HCV isolates can be classified into 9 groups and 23 subgroups. The rationale for these classifications and the epidemiological and clinical implications of genotyping HCV are reviewed.

Entities:  

Mesh:

Year:  1994        PMID: 7814244     DOI: 10.1159/000150360

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  17 in total

Review 1.  Autoimmunity in liver diseases.

Authors:  C P Strassburg; P Obermayer-Straub; M P Manns
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

2.  Distribution of HCV genotypes among risk groups in Serbia.

Authors:  G Stamenkovic; S Zerjav; Z M Velickovic; K Krtolica; V L Samardzija; L Jemuovic; D Nozic; B Dimitrijevic
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

3.  Sequence heterogeneity of TT virus and closely related viruses.

Authors:  Y E Khudyakov; M E Cong; B Nichols; D Reed; X G Dou; S O Viazov; J Chang; M W Fried; I Williams; W Bower; S Lambert; M Purdy; M Roggendorf; H A Fields
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

4.  Assessment of commercial enzyme immunoassay for hepatitis C virus serotyping.

Authors:  L M Webber; S Els; M B Taylor; W O Grabow
Journal:  J Clin Pathol       Date:  1996-12       Impact factor: 3.411

5.  Antiviral effects of peginterferon alpha-2b and ribavirin following 24-week monotherapy of telaprevir in Japanese hepatitis C patients.

Authors:  Itaru Ozeki; Jun Akaike; Yoshiyasu Karino; Tomohiro Arakawa; Yasuaki Kuwata; Takumi Ohmura; Takahiro Sato; Naohiro Kamiya; Ichimaro Yamada; Kazuaki Chayama; Hiromitsu Kumada; Joji Toyota
Journal:  J Gastroenterol       Date:  2011-05-10       Impact factor: 7.527

Review 6.  The quasispecies of hepatitis C virus and the host immune response.

Authors:  P Farci; J Bukh; R H Purcell
Journal:  Springer Semin Immunopathol       Date:  1997

7.  Full-genome nucleotide sequence of a hepatitis C virus variant (isolate name VAT96) representing a new subtype within the genotype 2 (arbitrarily 2k).

Authors:  E I Samokhvalov; M Hijikata; R I Gylka; D K Lvov; S Mishiro
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

8.  Prevalence of hepatitis C virus and distribution of its genotypes in Northern Eurasia.

Authors:  D K Lvov; E I Samokhvalov; F Tsuda; N A Selivanov; H Okamoto; V M Stakhanova; I V Stakhgildyan; N V Doroshenko; T L Yashina; S N Kuzin; I A Suetina; P G Deryabin; L A Ruzaeva; V N Bezgodov; L A Firsova; S N Sorinson; S Mishiro
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

9.  Second-generation line probe assay for hepatitis C virus genotyping.

Authors:  L Stuyver; A Wyseur; W van Arnhem; F Hernandez; G Maertens
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

10.  Increased rate of death related to presence of viremia among hepatitis C virus antibody-positive subjects in a community-based cohort study.

Authors:  Hirofumi Uto; Sherri O Stuver; Katsuhiro Hayashi; Kotaro Kumagai; Fumisato Sasaki; Shuji Kanmura; Masatsugu Numata; Akihiro Moriuchi; Susumu Hasegawa; Makoto Oketani; Akio Ido; Kazunori Kusumoto; Satoru Hasuike; Kenji Nagata; Michinori Kohara; Hirohito Tsubouchi
Journal:  Hepatology       Date:  2009-08       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.